BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32799612)

  • 1. Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia.
    Chu T; Wang H; Lv X; Qi J; Tang Y; Fan Y; Qiu H; Tang X; Fu C; Ruan C; Han Y; Wu DP
    Platelets; 2021 Jul; 32(5):677-683. PubMed ID: 32799612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
    Li S; Gao Y; Li F; Zheng Y; Su Y
    Ann Hematol; 2023 Apr; 102(4):787-794. PubMed ID: 36750485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
    Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
    Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of Chinese disseminated intravascular coagulation scoring system (version 2017) in patients with acute promyelocytic leukemia].
    Huang YT; Liu XF; Fu RF; Chen YF; Liu W; Xue F; Zhang L; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):480-484. PubMed ID: 30032565
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
    Lee HJ; Kim DH; Lee S; Koh MS; Kim SY; Lee JH; Lee S; Oh SY; Han JY; Kim HJ; Kim SH
    Korean J Intern Med; 2015 Nov; 30(6):884-90. PubMed ID: 26552464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.
    Kim DY; Lee JH; Lee JH; Kim SD; Lim SN; Choi Y; Lee YS; Kang YA; Seol M; Jeon M; Kim JY; Lee KH; Lee YJ; Lee KH
    Leuk Res; 2011 Feb; 35(2):152-8. PubMed ID: 20554322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥ 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia.
    Mitrovic M; Suvajdzic N; Bogdanovic A; Kurtovic NK; Sretenovic A; Elezovic I; Tomin D
    Med Oncol; 2013 Mar; 30(1):478. PubMed ID: 23371042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome.
    Yanada M; Matsushita T; Asou N; Kishimoto Y; Tsuzuki M; Maeda Y; Horikawa K; Okada M; Ohtake S; Yagasaki F; Matsumoto T; Kimura Y; Shinagawa K; Iwanaga M; Miyazaki Y; Ohno R; Naoe T
    Eur J Haematol; 2007 Mar; 78(3):213-9. PubMed ID: 17241371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia.
    Higuchi T; Shimizu T; Mori H; Niikura H; Omine M
    Hematol Oncol; 1997 Nov; 15(4):209-17. PubMed ID: 9722892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia.
    Xiao M; Zhou P; Liu Y; Wei S; Li D; Li W; Niu X; Niu J; Zhang Y; Cao W; Liu B; Wang X; Bai Y; Sun K
    Thromb Res; 2022 Feb; 210():33-41. PubMed ID: 34998209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
    Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between D-Dimer/Fibrinogen Ratio and Bleeding in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
    Li SS; Yang XW; Zheng Y; Gao YJ; Su YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1340-1344. PubMed ID: 37846682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.
    Zhang Y; Wu S; Luo D; Zhou J; Li D
    PLoS One; 2016; 11(1):e0147545. PubMed ID: 26812490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of early hemorrhage in acute promyelocytic leukemia.
    Naymagon L; Moshier E; Tremblay D; Mascarenhas J
    Leuk Lymphoma; 2019 Oct; 60(10):2394-2403. PubMed ID: 30849255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperfibrinolysis Is an Important Cause of Early Hemorrhage in Patients with Acute Promyelocytic Leukemia.
    Song YH; Qiao C; Xiao LC; Zhang R; Lu H-
    Med Sci Monit; 2018 May; 24():3249-3255. PubMed ID: 29771870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts.
    Ono T; Takeshita A; Kishimoto Y; Kiyoi H; Okada M; Yamauchi T; Emi N; Horikawa K; Matsuda M; Shinagawa K; Monma F; Ohtake S; Nakaseko C; Takahashi M; Kimura Y; Iwanaga M; Asou N; Naoe T;
    Cancer Sci; 2014 Jan; 105(1):97-104. PubMed ID: 24206578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosis.
    Bai Y; Shi M; Yang X; Zhang W; Yang R; Wei X; Wei X; Duan L; Wang C; Mi R; Waqas Ahmed HA; Huo L; Chen Y; Xu F; Wu D; Sun K
    Leuk Res; 2019 Apr; 79():34-37. PubMed ID: 30831481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.